Phosphate glass fibrous scaffolds: tailoring of the properties and improvement of the bioactivity through the incorporation of mesoporous glasses

Introduction. Synthetic bone scaffolds are proposed as an alternative to the use of bone grafting technique for bone regeneration. Porous scaffold obtained from glass fibres randomly arranged into a mould shows an interconnected porosity generated by the free space between fibres and they do not need of any further material or processing step before sintering. In this work, a resorbable phosphate glass was selected for the fibre drawing and bioactive mesoporous glasses with different morphology and size were incorporated into the fibrous scaffold to combine the resorption property of the fibres with the bioactivity of the mesoporous powders. Materials and methods. Fibres of a TiO2-containing phosphate glass (TiPS2.5) were fabricated following the preform drawing approach as described elsewhere [1]. A dense silica-based bioactive glass (CEL2) [2] was produced by melt quenching as reference sample. Spherical micro-sized mesoporous glass based on SiO2-CaO system (SD_MBG) was produced by an aerosol-assisted spray-drying technique [3]. Cu-containing (85SiO2-13CaO-2CuO, % mol, referred as Cu_BGn2%) mesoporous glass nanoparticles were synthetized by an ultra-sound assisted sol-gel method to impart antibacterial properties. To fabricate the fibrous scaffolds, the selected powder and phosphate glass fibres, cut at precise length, were placed in a beaker containing 2 ml of ethanol. After ethanol evaporation, the powder/fibre mixture was randomly placed inside a zirconia cylindrical mould [4]. After the thermal treatment, the scaffolds were analyzed through micro-CT in order to investigate their inner structure. Furthermore, their ability to form hydroxyapatite was studied by soaking them in a simulated body fluid (SBF). The scaffold morphology before and after immersion in SBF was studied by FESEM. Results and discussion. FESEM micrographs show that CEL2 are not well incorporated into the fibre surface. On the contrary, SD-MBG (Figure 1.a, Figure 1.b and Figure 1.d) and Cu_BGn2% particles homogeneously cover the whole surface. Micro-CT analysis did not reveal the presence of powder agglomerates for all the observed scaffolds and showed a homogeneous porosity of 58 vol.% for CEL2/fibre scaffold, 53 vol.% for SD_MBG/scaffold (Figure 1.c) and 33% for Cu_BGn2%/scaffold. In CEL2/fibre scaffolds, glass particles were removed during soaking in SBF, leaving some pits on the fibre surface: FESEM analysis revealed few particles still anchored to the scaffold surface after 7 days. On the contrary, after 7 days in SBF, SD-MBG and Cu_BGn2% particles were clearly visible on the surface of the scaffolds and after 1 day of soaking in SBF, they appeared (Figure 2) fully covered with a HA layer, showing the typical "cauliflower-like" morphology. Conclusion. The incorporation of mesoporous bioactive glass powder in the phosphate glass fibrous scaffold resulted to be a very interesting strategy to impart multifunctional properties to the scaffold. These promising results encourage further investigation in order to fully exploit the ability of mesoporous particles to act as a system for smart release of therapeutic ions and drugs.